Vol. 15 No. 1 (2023)

Artigos

• Prevalence of multiple sclerosis in patients treated with disease-modifying drugs using data from the Brazilian Unified Health System

  Juares Bianco, Alfredo Damasceno, Jefferson Becker, Fabiana Casarin, Nayara Carlos, Tamiê Martins, Priscila Yazawa

  12-23

  • PDF (Português (Brasil))

• The impact of depression in the Brazilian private healthcare system: patient journey and economic burden study associating claim database and expert’s opinion approach

  Marco Antonio Matos, Alberto Ogata, Carmita Abdo, Celso Gondo, Maria Teresa Lodi, Stephen Stefani, Elizabeth Bilevicius

  24-31

  • PDF

• The impact of patients with generalized anxiety disorder in the Brazilian Private Healthcare System: a claim database study with expert’s perspective

  Marco Antonio Matos, Alberto Ogata, Celso Gondo, Luiz Dieckman, Stephen Stefani, Teng Chei Tung, Elizabeth Bilevicius

  32-38

  • PDF (Português (Brasil))

• Depression severity, treatment response and PRO (disability and QoL) in TRD patients over a 1-year follow-up with standard of care: Analysis of the Brazilian subset of the multicenter, observational TRAL study

  Marco Antonio Caldieraro, Chei Tung Teng, Acioly L. T. Lacerda, Lucas C. Quarantini, Hamilton Grabowsiky, Gabriela Kanevsky, Sergio Perocco

  38-51

  • PDF (Português (Brasil))

• Budget impact analysis of PARP inhibitors in the treatment of advanced ovarian cancer from on real-world evidence the perspective of a federal hospital reference in oncology

  Carolina Martins, Raquelaine Padilha, Isandra Meirelles, Eduardo Paulino, Rodrigo Costa

  52-58

  • PDF (Português (Brasil))

• The impact of COPD on the private healthcare system in Brazil: an economic analysis

  Oliver Nascimento, Luciana Saturnino, Felipe Santos, Danielle Silva, Mariana Gazzotti, Franco Martins, Ana Luisa Gomes, Karynna Viana, Rafael Alfonso-Cristancho, Claudia Rodrigues

  59-66

  • PDF (Português (Brasil))

• Innovative mechanisms of pre-marketing authorization access for rare diseases in Brazil: a case study of pabinafusp-alfa for mucopolysaccharidosis type II

  Maicon Falavigna, Celina Migliavaca, Elio Tanaka, Marcos Santos

  67-70

  • PDF (Português (Brasil))

• Phlebitis associated with peripheral venous catheter in cardiology: incidence, risk factors and associated costs

  Sílvia Ribeiro, Sara Valente, Salomé Sousa, Marisa Lopes, Nuno Abreu, Eduardo Alves

  71-80

  • PDF (Português (Brasil))

• Pluri-social participation to increase inclusion and assertiveness in health decision-making related to osteoporosis treatments

  Pérola G. Papler, Bruna Rocha, Eliane Cortez, Luciana L. Mensor

  81-87

  • PDF (Português (Brasil))